Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /002589
chevron_leftBack
Realcan Pharmaceutical Group Co., Ltd. logo

Realcan Pharmaceutical Group Co., Ltd.

002589
SHE: 002589 Delayed
3.18CNY -2.2%
0.4698 USD
As of 6 June 2026, Realcan Pharmaceutical Group Co., Ltd. has a market cap of $712.59M USD, ranking #12838 globally and #3849 in China. It ranks #1173 in the Healthcare sector, and #67 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
12838
Country Rank
3849
Sector Rank
1173
Industry Rank
67
Key Stats
Market Cap
$712.59MUSD
4.82B CNY
Enterprise Value
$729.95MUSD
4.94B CNY
Revenue (TTM)
$1.07BUSD
7.25B CNY
EBITDA (TTM)
$40.32MUSD
272.96M CNY
Net Income (TTM)
$2.12MUSD
14.35M CNY
EBITDA Margin
3.8%
Profit Margin
0.2%
PE Ratio
336.0
PS Ratio
0.7
PB Ratio
0.9
EV/EBITDA
16.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Xu Han open_in_new
Employees
2,897
Founded
2004
Website
realcan.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.2% -1.9% 2.9% -6.5% 9.7% 12%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
002589
瑞康医药集团股份有限公司 Class A
ISIN: CNE1000013X5
Shares Out.:
1.331B1 Shares Float: 917.133M2
TV:
SA:
YF:
GF:
BA:
MS:
3.18 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Realcan Pharmaceutical Group Co., Ltd.

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materials, herbal medicine, and patent medicine. It is also involved in the wholesale of biochemical, psychotropic, narcotic, and toxic drugs for medical use; chemical APIs, and preparations; antibiotics, biological products, anabolic steroids, peptide hormones, poppy shells, and pharmaceutical precursor chemicals; and medical devices. In addition, the company provides leasing of medical devices and technical services; investment management and consulting services; medical sterilization outsourcing and consulting services; health consulting services; and pharmaceutical logistics services. Further, it engages in the warehousing and distribution of drugs; technology development and transfer; and operation of a health service platform. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)
Name
Market Cap diff.
PE
$15.86B
107.34B CNY
2K%
16.0
$9.1B
61.6B CNY
1K%
80.6
$5.22B
35.33B CNY
632%
20.0
$4.21B
28.47B CNY
490%
20.8
$3.27B
22.12B CNY
359%
8.1
$2.74B
18.55B CNY
285%
11.5
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
5K%
24.2
$29.56B
4K%
-
CIPLA
$11.12B
1.06T INR
1K%
23.4
LUPIN
$11.0B
1.05T INR
1K%
22.7
$8.79B
7.57B EUR
1K%
-
AUROPHARMA
$8.43B
807.02B INR
1K%
23.1
chevron_leftBack